Know the status of your medication? Check Now

BLOOD or RED BLOOD CELL PRODUCTS (Administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous blood or red blood cell products of any origin into the circulatory system)

Prohibited method: BLOOD or RED BLOOD CELL PRODUCTS – refer to section M1 (Manipulation of blood and blood components) of the WADA 2022 Prohibited List.